We are live on !
Find out more
Rathbones Group Portfolio holdings
AUM
$27.1B
Turnover
12.71%
1-Year Est. Return
20.2%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.19%
AUM
$27.1B
AUM Growth
+$2.1B
(+8.4%)
Cap. Flow
+$4.87M
Cap. Flow % of AUM
Cap. Flow %
0.02%
Top 10 Holdings %
Top 10 Hldgs %
39.99%
Holding
700
New
54
Increased
201
Reduced
274
Closed
35
Avg Time Held
4.9
years
Top 10 Avg Time Held
5.7
years
Top 20 Avg Time Held
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$132M |
| 2 |
NVIDIA
NVDA
|
+$67.5M |
| 3 |
Marsh
MRSH
|
+$62.9M |
| 4 |
Goldman Sachs
GS
|
+$61.9M |
| 5 |
Monster Beverage
MNST
|
+$60.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$78.9M |
| 2 |
Accenture
ACN
|
+$78.2M |
| 3 |
O'Reilly Automotive
ORLY
|
+$75.1M |
| 4 |
Brown & Brown
BRO
|
+$69.8M |
| 5 |
Broadridge
BR
|
+$65.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.91% |
| 2 | Financials | 18.06% |
| 3 | Healthcare | 13.92% |
| 4 | Communication Services | 9.24% |
| 5 | Consumer Discretionary | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
iShares Global Healthcare ETF
IXJ
$4.59B
| $2.75M | 0.01% |
27,984
+2,243
| +9% | +$211K |
2023 Q3
11 quarters
|
|
277
Kimberly-Clark
KMB
$35.6B
| $2.73M | 0.01% |
24,910
-2,610
| -9% | -$259K |
2013 Q2
52 quarters
|
|
278
iShares Russell Mid-Cap Growth ETF
IWP
$19.3B
| $2.73M | 0.01% |
18,626
+71
| +0.4% | +$9.8K |
2014 Q1
49 quarters
|
|
279
Shell
SHEL
$299B
| $2.67M | 0.01% |
34,448
-157
| -0.5% | -$13.6K |
2022 Q1
17 quarters
|
|
280
Invesco International Corporate Bond ETF
PICB
$342M
| $2.64M | 0.01% |
114,025
-15,984
| -12% | -$375K |
2018 Q4
30 quarters
|
|
281
RadNet
RDNT
$5.42B
| $2.58M | 0.01% |
41,834
+506
| +1% | +$28.4K |
2023 Q3
11 quarters
|
|
282
Ametek
AME
$57.3B
| $2.56M | 0.01% |
10,576
-575
| -5% | -$132K |
2013 Q2
52 quarters
|
|
283
ProShares UltraPro QQQ
TQQQ
$36.4B
| $2.54M | 0.01% |
31,326
-640
| -2% | -$44.4K |
2023 Q4
10 quarters
|
|
284
WisdomTree Japan Hedged Equity Fund
DXJ
$8.01B
| $2.53M | 0.01% |
43,794
+4,923
| +13% | +$276K |
2013 Q2
52 quarters
|
|
285
Pan American Silver
PAAS
$17.9B
| $2.53M | 0.01% |
56,464
-14,450
| -20% | -$774K |
2023 Q3
11 quarters
|
|
286
Jackson Financial
JXN
$8.92B
| $2.52M | 0.01% |
24,615
-1,156
| -4% | -$125K |
2021 Q3
19 quarters
|
|
287
XPO
XPO
$22.2B
| $2.51M | 0.01% |
12,225
| – | – |
2023 Q3
11 quarters
|
|
288
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$111M
| $2.45M | 0.01% |
45,737
+3,529
| +8% | +$183K |
2018 Q4
30 quarters
|
|
289
Cohen & Steers Infrastructure Fund
UTF
$2.88B
| $2.43M | 0.01% |
87,931
-11,345
| -11% | -$305K |
2014 Q3
47 quarters
|
|
290
Nu Holdings
NU
$73.4B
| $2.42M | 0.01% |
180,975
-5,644
| -3% | -$76.1K |
2025 Q1
5 quarters
|
|
291
First Trust Emerging Markets AlphaDEX Fund
FEM
$796M
| $2.38M | 0.01% |
74,500
+14,863
| +25% | +$481K |
2018 Q4
30 quarters
|
|
292
ASP Isotopes
ASPI
$336M
| $2.37M | 0.01% |
381,619
-4,947
| -1% | -$29.1K |
2023 Q4
10 quarters
|
|
293
Moody's
MCO
$83.2B
| $2.34M | 0.01% |
5,176
| – | – |
2014 Q1
49 quarters
|
|
294
United Therapeutics
UTHR
$24B
| $2.32M | 0.01% |
4,289
+11
| +0.3% | +$6.2K |
2023 Q3
11 quarters
|
|
295
Becton Dickinson
BDX
$53.1B
| $2.3M | 0.01% |
15,171
-192
| -1% | -$28.7K |
2014 Q1
49 quarters
|
|
296
Arthur J. Gallagher & Co
AJG
$66.2B
| $2.25M | 0.01% |
9,796
-25,318
| -72% | -$5.38M |
2013 Q2
52 quarters
|
|
297
Carlisle Companies
CSL
$13.6B
| $2.24M | 0.01% |
6,178
| – | – |
2016 Q2
40 quarters
|
|
298
iShares Core S&P Small-Cap ETF
IJR
$104B
| $2.11M | 0.01% |
14,197
-6
| -0% | -$823 |
2023 Q3
11 quarters
|
|
299
Brookfield
BN
$84.1B
| $2.09M | 0.01% |
49,107
+632
| +1% | +$28.3K |
2014 Q4
46 quarters
|
|
300
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$28.9B
| $2.03M | 0.01% |
18,586
-40
| -0.2% | -$4.36K |
2023 Q3
11 quarters
|
|
Similar funds
Rathbones Group's Q2 2026 Portfolio in Review
As of Q2 2026, Rathbones Group held 700 positions worth $27.1B, up 8.4% from $25B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rathbones Group's Q2 2026 filing shows 54 new, 201 increased, 274 reduced and 35 closed positions. Its largest new stake was Monster Beverage: 1,447,724 shares worth $69.6M. The largest sale was Intuit, an estimated $78.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Rathbones Group's largest Q2 2026 buy was Monster Beverage: 1,447,724 shares worth $69.6M.
- Rathbones Group added most to Lam Research in Q2 2026, an estimated $132M increase.
- Rathbones Group's biggest Q2 2026 reduction was Intuit, cutting an estimated $78.9M.
- Rathbones Group fully exited Broadridge in Q2 2026, selling an estimated $65.4M.
- Rathbones Group's ten largest holdings make up 40% of its $27.1B portfolio in Q2 2026.
- Rathbones Group opened 54 new positions and closed 35 in Q2 2026.
- Rathbones Group's portfolio value rose 8.4% quarter-over-quarter to $27.1B.
Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.